Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by Bucknelly21on Jan 17, 2020 11:17am
219 Views
Post# 30565157

No interest

No interest It's been months and months of meetings, conferences and throw and r&d day in there. In my opinion I really like them as people they are competent and very good at the details, however it's probably safe to say that something even with the Nash opportunity is not attractive to institutional buyers at the moment and I can't really pin point what it could be other that not being sold by who ever is presenting thtx's prospects. It's not working, I get the sense that they keep trying the same thing over and over and over expecting different outcomes. I could be wrong but I truly think that some poster in here could sell the story better than the company does. That's an issue to me. Look at madrigal they own the label of the most likely to breakout as one of the top. A much younger company and they are way more transparent on what's going on, they don't hide and they sell the idea that they are the #1 nash company period, even burning through the amount of money they do it doesn't matter to the people that are investing in them. Thtx on the other hand has 2 drugs that would badly received and marketed however they do provide revenue and they have a potential huge opportunity with nafdl/Nash. No one is talking about it beside us, no one cares beside us. As much as I don't like to put the blame on them I have to on this one, it's not a hard story to sell, especially at this price. So what is the issue, in my opinion they move way too slow. An ir person should have been in place when they went to nasdaq. Grinspoon needs to be super involved in this and they need to tell ya what's going on, I'm so tired of this guessing garbage, they aren't protecting any advantage they have because no one is even targeting the hiv Nash market. So all this playing the cards close to you chest does is make you look weak and or not trustworthy. I believe that they are trustworthy but I also think they are stubborn and don't take advise well, because if they did we would see something different. "New marketing initiative" ok.... well what is it!!!!! It shouldn't be Sherlock episode every pr. Pr's are meant to clarify not confuse. Despite how much I like luc and Phillipe I just am slowing drifting back to not sure that they will be able to capitalize on all the opportunities in front of them when it comes to selling the story.
Bullboard Posts